Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ULHAS M NADGIR

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1629079215
CMS profile
119558
Location
SACRAMENTO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$2,689.44

153 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,689.44 153

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ULHAS M NADGIR

NPI 1629079215 · CMS profile ID 119558

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

SACRAMENTO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629079215?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ULHAS M NADGIR, NPI 1629079215, CMS profile ID 119558. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629079215?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ULHAS M NADGIR, NPI 1629079215, CMS profile ID 119558. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629079215?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ULHAS M NADGIR, NPI 1629079215, CMS profile ID 119558, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1629079215?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

153 matching records · $2,689.44 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 153 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 153.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alexion Pharmaceuticals, Inc. $24.4805/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914838005 CMS
Xeris Pharmaceuticals, Inc. $13.5804/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946497471 CMS
Mannkind Corporation $19.7004/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942762183 CMS
TOLMAR Pharmaceuticals, Inc. $18.8704/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954467343 CMS
Ascendis Pharma, Inc. $29.8104/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942556697 CMS
Novo Nordisk Inc $7.5404/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898816247 CMS
ABBVIE INC. $10.1504/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227193 CMS
Alexion Pharmaceuticals, Inc. $21.8704/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915413181 CMS
ABBVIE INC. $8.8104/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227191 CMS
Novo Nordisk Inc $6.8504/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898816373 CMS
Novo Nordisk Inc $23.0403/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898537383 CMS
Ascendis Pharma, Inc. $25.1603/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942555256 CMS
Lilly USA, LLC $21.5903/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918288373 CMS
Zealand Pharma US, Inc. $21.5803/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905966843 CMS
Abbott Laboratories $20.0803/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907935899 CMS
Ultragenyx Pharmaceutical Inc. $22.2103/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963735721 CMS
Ultragenyx Pharmaceutical Inc. $17.2603/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963735487 CMS
Insulet Corporation $20.8703/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933129583 CMS
Mannkind Corporation $20.9303/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942762181 CMS
ABBVIE INC. $23.6203/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227189 CMS
Abbott Laboratories $22.7803/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920542139 CMS
Abbott Laboratories $1.9703/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920542145 CMS
Novo Nordisk Inc $6.7403/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899342271 CMS
Zealand Pharma US, Inc. $14.6803/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905966841 CMS
TOLMAR Pharmaceuticals, Inc. $20.7703/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954483075 CMS
Novo Nordisk Inc $16.0203/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898866255 CMS
ABBVIE INC. $22.4403/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227185 CMS
ABBVIE INC. $1.1103/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227187 CMS
Ascendis Pharma, Inc. $26.0402/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942552301 CMS
ABBVIE INC. $9.0102/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227183 CMS
Abbott Laboratories $19.1502/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920542151 CMS
Zealand Pharma US, Inc. $22.6202/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905966847 CMS
Mannkind Corporation $25.7602/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942762179 CMS
Novo Nordisk Inc $7.5802/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898817403 CMS
Lilly USA, LLC $23.1402/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918325293 CMS
Medtronic, Inc. $22.6902/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933470227 CMS
Zealand Pharma US, Inc. $19.4002/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905966849 CMS
Tandem Diabetes Care, Inc. $21.8002/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963182471 CMS
ABBVIE INC. $19.8802/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227181 CMS
Ascendis Pharma, Inc. $28.0301/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942550647 CMS
Novo Nordisk Inc $7.6701/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898816773 CMS
Mannkind Corporation $18.6001/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942762177 CMS
BioMarin Pharmaceutical Inc. $23.8401/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929751821 CMS
BioMarin Pharmaceutical Inc. $1.3501/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929751865 CMS
IBSA Pharma Inc. $16.3201/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890038166 CMS
ABBVIE INC. $12.9301/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891227179 CMS
Novo Nordisk Inc $5.7201/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898832105 CMS
LIFESCAN, INC. $20.1201/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 919453697 CMS
TOLMAR Pharmaceuticals, Inc. $22.2501/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954467337 CMS
Alexion Pharmaceuticals, Inc. $13.9501/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914952223 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,020.37 73
PY2020 $957.17 64
PY2021 $1,865.07 118
PY2022 $2,689.44 153
PY2023 $2,448.46 141
PY2024 $938.35 46
PY2025 $3,752.77 76

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $384,077.40 12
PY2023 Principal investigator $30,658.20 6
PY2022 Principal investigator $136,290.84 34
PY2021 Principal investigator $130,052.84 18
PY2020 Principal investigator $7,105.50 3
PY2019 Principal investigator $19,524.74 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 2 Dexcom, Inc. $7,553.00 11/12/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126173
Principal investigator 2 Dexcom, Inc. $1,634.25 09/24/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126165
Principal investigator 2 Dexcom, Inc. $75,000.00 08/27/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126157
Principal investigator 2 Dexcom, Inc. $16,953.05 08/27/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126161
Principal investigator 2 Dexcom, Inc. $16,615.20 08/27/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126169
Principal investigator 2 Dexcom, Inc. $58,013.00 06/18/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
EVALUATION OF THE PERFORMANCE AND DATA DELIVERY RELIABILITY OF THE DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM No dispute reported 06/30/2026 1154126185
Principal investigator 1 AstraZeneca UK Limited $3,597.90 05/24/2024 Non-covered Recipient Entity
CENTER OF EXCELLENCE IN DIABETES AND ENDOCRINOLOGY
In pediatric Type two Diabetes Mellitus T2DM subjects on diet and exercise and metformin,or insulin,or metformin and insuline The primary research hypothesis for dapagliflozin is whether addition of dapagliflozin,results in a greater mean reduction from baseline in glycosylated hemoglobin HbA1c as compared to placebo when each are administered over 26 weeks of oral double blind add on treatment No dispute reported 06/30/2026 1110837762
Principal investigator 2 Dexcom, Inc. $12,578.00 02/09/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126144
Principal investigator 1 Dexcom, Inc. $12,085.00 02/09/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126149
Principal investigator 2 Dexcom, Inc. $125,760.00 01/09/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
FEASIBILITY STUDY OF EVALUATION OF THE PERFORMANCE OF THE MODIFIED G7 DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM No dispute reported 06/30/2026 1154126177
Principal investigator 2 Dexcom, Inc. $39,800.00 01/03/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1154126153
Principal investigator 2 Dexcom, Inc. $14,488.00 01/03/2024 Non-covered Recipient Entity
Center of Excellence in Diabetes and Endocrinology
EVALUATION OF THE PERFORMANCE AND DATA DELIVERY RELIABILITY OF THE DEXCOM CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM No dispute reported 06/30/2026 1154126181